Evidence Hub

Traditional Chinese Medicine for Acute Migraine: A Systematic Review and Meta-Analysis

Xiujuan Xue, Jie Lv, Hongjian Gui, Lin Wang, Yajie Zhang, Songtao Wu, Li-Jia Jiang, Li-Na Wang et al.

Current Research in Medical Sciences, 2024

399 participants

Abstract

Objectives: A meta-analysis of traditional Chinese medicine in the treatment of acute migraine was conducted to obtain a consistent evaluation of its efficacy. Methods: The search databases were China National Knowledge Infrastructure (CNKI), Wanfang, VIP, Chinese Biomedical Literature Database (CBM) and PubMed. The publication time of randomized controlled studies (RCT) documents is limited to before June 30, 2023. Results: Data from 399 patients from 5 RCTs were included. Compared with Western medicine, Traditional Chinese medicine has a higher efficacy ([RR=0.81, 95%CI (0.75, 0.89), P<0.00001]), a lower adverse reaction rate ([RR=1.37, 95%CI (0.74, 2.54), P=0.32]) and an improved VAS ([MD=-1.37, 95%CI (-2.00, -0.75), P<0.00001]). Conclusion: Traditional Chinese medicine in the treatment of acute migraine can enhance clinical efficacy, reduce treatment side effects, and improve patients’ visual analogue score.

How strong is the evidence?

Evidence Hub reads this as a meta-analysis. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 399 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free